Laekna raises $61m to accelerate product development
The company launched six clinical programmes, with three multi-regional clinical trials for cancers.
Clinical Trials
Latest in
Clinical Trials
Sound Pharmaceuticals receives NIH grant for Covid-19 therapy development
The grant will support two trials of ebselen in 120 adult subjects with moderate or severe Covid-19.
EC approves Horizon’s Uplizna for neuromyelitis optica spectrum disorder
The latest approval is based on findings from the Phase II/III N-MOmemtum clinical trial carried out in 25 countries.
Pharma fundraising in the digital age: HCS Pharma dives into crypto
HCS Pharma is amidst a EUR7m raise using crypto tokens. The firm’s CEO offers some tips for other companies considering…
By
Amylyx AdCom: panelists narrowly vote against FDA approval in ALS despite strong patient advocacy
Some FDA panelists cited concerns with the ALS trial design, while others pointed to positive data and the high unmet…
By
EMA initiates review of CSL Behring’s gene therapy for Haemophilia B
The application is backed by positive data from the Phase III HOPE-B trial of etranacogene dezaparvovec in haemophilia B patients.
Vitiligo: all eyes on further Phase III data for Incyte’s ruxolitinib at AAD
With the FDA calling for more data on the JAK inhibitor in vitiligo, Incyte’s presentation is one to look out…
By
Clinical trials in Russia: big pharma makes moves but what’s the pipeline impact?
Certain big pharma companies have reconsidered their clinical trial footprint in Russia in response to the Ukraine invasion. Clinical Trials…
By